XE
Xenon Pharma
XENE·NASDAQBurnaby CAFounded 1996200 employees
Mid CapbiotechPublicNeurology
Platform: Nav1.6 Ion Ch
Market Cap
$4B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (XENE)
Loading XENE stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Surarasimod | XEN-2642 | Phase 2 | 1 | SHP2 | Endometrial CaFSGS | ||
| XEN-577 | XEN-577 | Phase 2/3 | 2 | C5 | Myelofibrosis | ||
| Pemitinib | XEN-4674 | Preclinical | 2 | BTK | Endometrial CaProstate Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)